Metformin ameliorates the Phenotype Transition of Peritoneal Mesothelial Cells and Peritoneal Fibrosis via a modulation of Oxidative Stress
Abstract Phenotype transition of peritoneum is an early mechanism of peritoneal fibrosis. Metformin, 5′-adenosine monophosphate-activated protein kinase (AMPK) activator, has recently received a new attention due to its preventive effect on organ fibrosis and cancer metastasis by inhibiting epitheli...
Guardado en:
Autores principales: | Hyun-Soo Shin, Jiyeon Ko, Dal-Ah Kim, Eun-Sun Ryu, Hye-Myung Ryu, Sun-Hee Park, Yong-Lim Kim, Eok-Soo Oh, Duk-Hee Kang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3bc1de470b4645c0994c76ee0c2f8e46 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Mesothelial-to-Mesenchymal Transition and Exosomes in Peritoneal Metastasis of Ovarian Cancer
por: Lucía Pascual-Antón, et al.
Publicado: (2021) -
Hydrogen sulfide inhibits epithelial-mesenchymal transition in peritoneal mesothelial cells
por: Shengnan Cheng, et al.
Publicado: (2018) -
The clinicopathologic significance of Tks5 expression of peritoneal mesothelial cells in gastric cancer patients.
por: Atsushi Sugimoto, et al.
Publicado: (2021) -
Retinoic acid improves morphology of cultured peritoneal mesothelial cells from patients undergoing dialysis.
por: Carmen Retana, et al.
Publicado: (2013) -
Inhibition of CTGF ameliorates peritoneal fibrosis through suppression of fibroblast and myofibroblast accumulation and angiogenesis
por: Norihiko Sakai, et al.
Publicado: (2017)